A year
SAFETY OBSERVER Nabo-1Y
PAGES
11 Consecutives Issues, starting with the next release
(includes a double issue for July/August)
PUBLICATIONS / NUMBER abo-1Y
Stay on top of all key Pharmacovigilance Regulatory requirements
We do the search and bring you the regulatory information you need to achieve compliancein your Pharmacovigilance operations.
Latest ReleaseSafety observer 137EMA: More detail about New EudraVigilance
EMA: Draft Paediatric GVP Chapter
EMA: First Public Hearing in September
EMA: New guideline for first-in-human trials
New PV Guidelines in ZA, MX and AU
Safety observer 136New FDA draft guidance on Electronic Records
EMA prepares launch of New EudraVigilance
EU Clinical Trial Regulation delayed
EMA takes further steps to prepare for Brexit
ABPI suspends Astellas UK over safety concerns
Safety observer 135EMA sets launch date for New EudraVigilance
EU Authorities clarify Brexit implications
Regulatory Action over PV System failures
FDA requests removal of Opana ER
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
